Stock Price Quote

KIMIA BIOSCIENCES LTD.

NSE : NABSE : 530313ISIN CODE : INE285U01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE37.88-0.06 (-0.16 %)
PREV CLOSE ( ) 37.94
OPEN PRICE ( ) 36.26
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1555
TODAY'S LOW / HIGH ( )36.26 37.89
52 WK LOW / HIGH ( ) 31.2648.95
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1993
Management Info
Sameer Goel - Chairman Sameer Goel - Managing Director
Registered Office

Address Village Bhondsi,Tehsil Sohna,Gurgaon Dist,
Bhondsi,
Haryana-122102

Phone 09654746544, 09654206544

Email compliance.kimia@gmail.Com

Website www.kimiabiosciences.com

Registrars Details
Beetal Financial & Computer Services (P) Ltd
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi
Listing : BSE, Ahmedabad, Chennai, Delhi, Jaipur

NEWS

22Sep Kimia Biosciences informs about issue
Pursuant to regulation 39(3) of SEBI (LODR) 2015, Kimia Biosciences has..
21Aug Kimia Biosciences informs about detail
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure..
14Jul Intimation Under Regulation 30 Of Int
The Company is pleased to inform you that Company had filed an applicati..
06May Kimia Biosciences informs about disclo
Pursuant to Circular No SEBI/HO/DDHS CIR/P/2018/144 dated 26th November,..
28Feb Kimia Biosciences informs about detail
In reference to the earlier intimation dated 27.02.2023, and pursuant to..

Financials

in Millions
QTR Jun 23 ANNUAL 23
Net Profit-27.11-93.5200000000001
Gross Profit -36.22 -123.88
Operating Profit -15.14-37.6300000000001
Net Sales 242.31285.16

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  3644.85 (2.20%)
M.Cap ( in Cr)4676.30
Astrazeneca Pharma I (BSE)
peergroup  4587.60 (1.71%)
M.Cap ( in Cr)11469.00
Bajaj Healthcare (BSE)
peergroup  464.90 (5.71%)
M.Cap ( in Cr)1283.05
NGL Fine-Chem (BSE)
peergroup  1994.80 (1.19%)
M.Cap ( in Cr)1232.39
Themis Medicare (BSE)
peergroup  1722.50 (1.28%)
M.Cap ( in Cr)1585.18

Shareholding Pattern

PROMOTERS 74.94%
NON-INSTITUTION 24.68%
MUTUAL FUNDS/UTI 0.38%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Kimia Biosciences Ltd.

Kimia Biosciences Ltd. was incorporated in the year 1993. Its today's share price is 37.88. Its current market capitalisation stands at Rs 179.22 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1249.01 Cr and Total Income of Rs.1258.33 Cr. The company's management includes Mita Namonath Jha, Lakshay Prakash, Vipul Goel, Richa Gupta, Jagdeep Dhawan, Sameer Goel, Sameer Goel.

It is listed on the BSE with a BSE Code of 530313 , NSE with an NSE Symbol of and ISIN of INE285U01025. It's Registered office is at Village Bhondsi,Tehsil Sohna,Gurgaon DistBhondsi-122102, Haryana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AK Jalan & Associates, Singhi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.